Type 1 Diabetes - Complications Pathogenesis and Alternative Treatments.pdf

Type 1 Diabetes - Complications, Pathogenesis, and Alternative Treatments

Edited by Chih-Pin Liu, ISBN 978-953-307-756-7, 482 pages, Publisher: InTech, Chapters published November 21, 2011 under CC BY 3.0 license
DOI: 10.5772/1540
Edited Volume

Changes were made to the original version: Chapter 23 added with a brief introduction and 2 articles:
- Repurposing of bacillus Calmette-Guerin (BCG): Prevention, remission or cure in Type 1 diabetes?
By Gupta OP, J Mahatma Gandhi Inst Med Sci 2015;20:121-2
- Proof-of-Concept, Randomized, Controlled Clinical Trial of Bacillus-Calmette-Guerin for Treatment of Long-Term Type 1 Diabetes
Denise L. Faustman,, Limei Wang, Yoshiaki Okubo, Douglas Burger, Liqin Ban, Hui Zheng, David Schoenfeld, Richard Pompei, Joseph Avruch, David M. Nathan, Guotong Man

These articles are also open access, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

These changes don’t reflect authors’ opinion on the subject.

Original work can be found at: Type 1 Diabetes - Complications, Pathogenesis, and Alternative Treatments

Index

Chapter 1 The Study of Glycative and Oxidative Stress in Type 1 Diabetes Patients in Relation to Circulating TGF-Beta1, VCAM-1 and Diabetic Vascular Complicationsby Vladimir Jakus, Jana Kostolanska, Dagmar Michalkova and Michal Sapak
Chapter 2 Diet, Lifestyle and Chronic Complications in Type 1 Diabetic Patientsby S.S. Soedamah-Muthu, S. Abbring and M. Toeller
Chapter 3 Lipid Disorders in Type 1 Diabetesby Bruno Vergès
Chapter 4 Prevalence of Type 1 Diabetes Correlates with Daily Insulin Dose, Adverse Outcomes and with Autoimmune Process Against Glutamic Acid Decarboxylase in Adultsby Mykola Khalangot, Vitaliy Gurianov, Volodymir Kovtun, Nadia Okhrimenko, Viktor Kravchenko and Mykola Tronko
Chapter 5 Type I Diabetes in Children and Adolescentsby Laura Nabors, Phillip Neal Ritchey, Bevin Van Wassenhove and Jennifer Bartz
Chapter 6 Inadequate Coping Attitudes, Disordered Eating Behaviours and Eating Disorders in Type 1 Diabetic Patientsby Ricardo V. García-Mayor and Alejandra Larrañaga
Chapter 7 Predictors of Adherence, Metabolic Control and Quality of Life in Adolescents with Type 1 Diabetesby M. Graça Pereira, A. Cristina Almeida, Liliana Rocha and Engrácia Leandro
Chapter 8 Contributing Factors to Poor Adherence and Glycemic Control in Pediatric Type 1 Diabetes: Facilitating a Move Toward Telehealthby Joseph P. H. McNamara, Adam M. Reid, Alana R. Freedland, Sarah E. Righi and Gary R. Geffken
Chapter 9 Fulminant Type 1 Diabetes Mellitus in IRS-2 Deficient Miceby Toshiro Arai, Nobuko Mori and Haruo Hashimoto
Chapter 10 Obesity in the Natural History of Type 1 Diabetes Mellitus: Causes and Consequencesby Fernando Valente, Marília Brito Gomes and Sérgio Atala Dib
Chapter 11 Meta-Analysis of Genome-Wide Association Studies to Understand Disease Relatednessby Stephanie N. Lewis, Elaine O. Nsoesie, Charles Weeks, Dan Qiao and Liqing Zhang
Chapter 12 Cytokine-Induced β-Cell Stress and Death in Type 1 Diabetes Mellitusby Lisa Vincenz, Eva Szegezdi, Richard Jäger, Caitriona Holohan, Timothy O’Brien and Afshin Samali
Chapter 13 A Novel L-Arginine/L-Glutamine Coupling Hypothesis: Implications for Type 1 Diabetesby Paulo Ivo Homem de Bittencourt Jr. and Philip Newsholme
Chapter 14 Diabetes Type 1 and 2: What is Behind a Classification?by Adriana Mimbacas and Gerardo Javiel
Chapter 15 The Enlarging List of Phenotypic Characteristics That Might Allow the Clinical Identification of Families at Risk for Type 1 Diabetesby Elena Matteucci and Ottavio Giampietro
Chapter 16 Altering Trends in the Epidemiology of Type 1 Diabetes Mellitus in Children and Adolescentsby Elisavet Efstathiou and Nicos Skordis
Chapter 17 Genetic Testing of Newborns for Type 1 Diabetes Susceptibility – The MIDIA Studyby Kjersti S. Rønningen
Chapter 18 Potentials and Limitations of Bile Acids and Probiotics in Diabetes Mellitusby Momir Mikov, Hani Al-Salami and Svetlana Golocorbin-Kon
Chapter 19 Role of Vitamin D in the Pathogenesis and Therapy of Type 1 Diabetes Mellitusby Agustin Busta, Bianca Alfonso and Leonid Poretsky
Chapter 20 Honey and Type 1 Diabetes Mellitusby Mamdouh Abdulrhman, Mohamed El Hefnawy, Rasha Ali and Ahmad Abou El-Goud
Chapter 21 Fatty Acid Supply in Pregnant Women with Type 1 Diabetes Mellitusby Éva Szabó, Tamás Marosvölgyi and Tamás Decsi
Chapter 22 Therapeutic Modelling of Type 1 Diabetesby Nilam Nilam, Seyed M. Moghadas and Pappur N. Shivakumar
Chapter 23 bacillus Calmette-Guerin (BCG): possible remission or cure in Type 1 diabetes
23.1 Introduction
23.2. Repurposing of bacillus Calmette-Guerin (BCG): Prevention, remission or cure in Type 1 diabetes?
Gupta OP, J Mahatma Gandhi Inst Med Sci 2015;20:121-2
23.3. Proof-of-Concept, Randomized, Controlled Clinical Trial of Bacillus-Calmette-Guerin for Treatment of Long-Term Type 1 Diabetes
Denise L. Faustman,, Limei Wang, Yoshiaki Okubo, Douglas Burger, Liqin Ban, Hui Zheng, David Schoenfeld, Richard Pompei, Joseph Avruch, David M. Nathan, Guotong Man